Kumar Neil
Chief Executive Officer
Kumar Neil has filed 20 SEC Form 4 filings (150 transaction rows) across 1 company, with disclosures dating back to 2025. 18 of those filings fall inside the rolling window. Most recent filing: Sep 21, 2026.
On the most recent filing, Kumar Neil is listed as Chief Executive Officer at BridgeBio Pharma, Inc. Inside the rolling window, Kumar Neil reported no open-market purchases and 23 open-market sales totaling $56.2M in BBIO. The largest disclosed transaction in the window is a sale of 40,000 BBIO shares on Jan 9, 2026, worth $3.1M.
Companies traded
Other insiders at BBIO
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$56.2M
reported sales (SEC code S)
Companies
1
in the rolling window
| Source | |||||||
|---|---|---|---|---|---|---|---|
| BBIO | Chief Executive Officer | Sale | 10,000 | $691K | Sep 21 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 34,980 | $2.9M | Aug 20 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 10,000 | $840K | Aug 20 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 35,921 | $2.4M | Jun 8 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 31,563 | $2.1M | Jun 8 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 26,103 | $1.8M | May 26 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.7M | May 11 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 39,050 | $2.6M | May 11 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $3.0M | Apr 13 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $3.0M | Apr 13 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 39,700 | $2.7M | Mar 16 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.8M | Mar 16 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 28,053 | $2.0M | Feb 23 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.9M | Feb 12 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.9M | Feb 12 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $3.0M | Jan 12 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $3.1M | Jan 12 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 30,011 | $2.2M | Dec 16 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $3.0M | Dec 8 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.9M | Dec 8 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 26,156 | $1.7M | Nov 24 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 39,900 | $2.5M | Nov 10 | SEC ↗ | |
| BBIO | Chief Executive Officer | Sale | 40,000 | $2.5M | Nov 10 | SEC ↗ |
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 9, 2025 | BBIO | Sale | $1.1M |
| Oct 9, 2025 | BBIO | Sale | $1.1M |
| Oct 8, 2025 | BBIO | Sale | $622K |
| Oct 8, 2025 | BBIO | Sale | $473K |
| Oct 8, 2025 | BBIO | Sale | $622K |
| Oct 8, 2025 | BBIO | Sale | $474K |
| Sep 5, 2025 | BBIO | Sale | $43K |
| Sep 5, 2025 | BBIO | Sale | $898K |
| Sep 5, 2025 | BBIO | Sale | $120K |
| Sep 5, 2025 | BBIO | Sale | $48K |
| Sep 5, 2025 | BBIO | Sale | $893K |
| Sep 5, 2025 | BBIO | Sale | $119K |
| Sep 4, 2025 | BBIO | Sale | $282K |
| Sep 4, 2025 | BBIO | Sale | $745K |
| Sep 4, 2025 | BBIO | Sale | $284K |
| Sep 4, 2025 | BBIO | Sale | $743K |
Frequently asked questions
How many SEC Form 4 filings has Kumar Neil made?
Kumar Neil has filed 20 SEC Form 4 filings (150 transaction rows) across 1 company since 2025.
Which companies does Kumar Neil trade?
Kumar Neil has filed SEC Form 4 disclosures for 1 company, including BBIO.
When was Kumar Neil's most recent SEC Form 4 filing?
Kumar Neil's most recent SEC Form 4 filing on Tracefour is dated Sep 21, 2026.
What is Kumar Neil's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kumar Neil is listed as Chief Executive Officer.
What is Kumar Neil's total buy and sell value in the current window?
Inside the rolling retention window, Kumar Neil bought $0 and sold $56.2M based on SEC Form 4 filings.
What was Kumar Neil's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 40,000 BBIO shares on 2026-01-09, worth $3.1M, per SEC Form 4 filings.